Table 1.
Illustration of clinic symptoms of patients allergic to hazelnut
| Patient | Age | Sex | Reported symptoms | CAP |
|---|---|---|---|---|
| # 1 |
57 |
F |
|
0 |
| # 2 |
33 |
F |
|
<0.35 |
| # 3 |
26 |
M |
Oral allergy syndrome |
2.68 |
| # 4 |
33 |
F |
Acute urticaria |
2.5 |
| # 5 |
16 |
F |
Avoidance |
2.97 |
| # 6 |
28 |
F |
Oral allergy syndrome |
4.03 |
| # 7 |
16 |
F |
Oral allergy syndrome |
2.08 |
| # 8 |
21 |
M |
Systemic anaphylaxis |
4.6 |
| # 9 |
26 |
F |
Rhinoconjunctivitis, angioedema, oral allergy syndrome |
0.58 |
| # 10 |
27 |
F |
Systemic anaphylaxis |
1.92 |
| # 11 |
30 |
M |
Oral allergy syndrome |
2.42 |
| # 12 |
42 |
F |
Oral allergy syndrome |
1.9 |
| # 13 |
28 |
M |
Avoidance |
0.87 |
| # 14 |
57 |
F |
Oral allergy syndrome |
2.5 |
| # 15 |
47 |
M |
Oral allergy syndrome |
4.13 |
| # 16 |
30 |
F |
Avoidance |
0.42 |
| # 17 | 49 | M | Avoidance | 0.47 |
Patients allergic to hazelnut proteins showed clinic symptoms from oral allergy syndrome, acute urticaria, systemic anaphylaxis, rhinoconjunctivitis, angioedema to avoidance (avoidance: advised to avoid hazelnut food because of a positive skin test). The resulting data including the age and sex, are illustrated in this table. (Note: F: female, M: male).
Avoidance*: advised to avoid the food because of a positive skin test, without a clinical history of hazelnut allergy.